Earendil Labs
Earendil Labs
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
About
What does Earendil Labs do?
Earendil Labs is an AI-powered biotechnology company advancing next-generation biologics for patients with autoimmune diseases, cancer, and other areas of significant unmet medical need. They integrate artificial intelligence across the full R&D lifecycle, from target identification and molecular design to optimization and clinical progression, to systematically generate and advance high-quality therapeutic programs.
What is Earendil Labs's revenue?
StartupHub estimates Earendil Labs's annual revenue at $67.3M (range $34.5M to $217.8M, 44% confidence), based on comparable companies in the sector.
What is Earendil Labs's valuation?
StartupHub estimates Earendil Labs's effective valuation at $1.1B (range $755.0M to $1.4B, 41% confidence), based on comparable companies in the sector.
How much funding has Earendil Labs raised?
Earendil Labs has raised a total of $787M in funding. The most recent round on record is Funding Round.
Where is Earendil Labs headquartered?
Earendil Labs is headquartered in Beijing, China.
When was Earendil Labs founded?
Earendil Labs was founded in 2024.
What industry does Earendil Labs operate in?
Earendil Labs operates in Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals, AI Drug Discovery, Biotech.
No comments yet. Be the first to share your take.